http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009058258-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d7b40925583f71d1a2c9460e562a9d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb224eea4e7c3141caef5570d06065b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee602c630e57f59c6cfc1c1634e36064
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36103
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3615
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0551
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-00
filingDate 2008-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82055379d5a45435f79362a4ec22cb32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d7dbd1eeac12434271e976a98a90f49
publicationDate 2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009058258-A1
titleOfInvention Onset-mitigating high-frequency nerve block
abstract A method of blocking signal transmission through a nerve with reduced onset activity includes applying an HFAC to an axon of a nerve to block the transmission of signals through the axon. The method may also include applying a direct current (DC) to the axon, increasing the amplitude of the DC over time to a predetermined amplitude, applying the HFAC, and then decreasing the DC. The method may also include temporarily reducing the amplitude of the HFAC to permit the transmission of signals through the axon and subsequently increasing the amplitude to block transmission without triggering an onset response. The method may also include temporarily applying an unbalanced charge to the nerve and then balancing the charge over time.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018037127-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018218018-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9072886-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8843188-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015109023-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8406886-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8738137-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3932471-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019133784-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018019856-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011125216-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201709-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10039917-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8862225-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021060344-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016132330-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925374-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757554-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9072896-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10413731-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758723-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8332029-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8467880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013514141-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015142838-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9364661-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10456575-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10406362-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8731676-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016235969-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8983612-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9254389-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018397759-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8483820-B2
priorityDate 2007-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6275735-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005149148-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007185549-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID52152
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID52152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516820
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73706

Total number of triples: 68.